Trinity Cap (NASDAQ:TRIN) 주식

Trinity Cap

Trinity Capital Inc is a closed-end, non-diversified management investment company. The company is engaged in providing debt, including loans and equipment financings, to growth-stage companies, including venture-backed companies and companies with institutional equity investors. Its equipment financings involve loans for general or specific use, including acquiring equipment, secured by the equipment or other assets of the portfolio company.

Trinity Capital Inc

Trinity Capital Inc. - 7.875% Notes Due 2029

Trinity Capital Inc Nt

Trinity Capital Inc. - 7.875% Notes due 2029

TRINEX MINERALS LTD by TRINEX MINERALS LTD.

Trinet Group Inc

Trinity Bank NA

Trinity Biotech plc - American Depositary Shares

Trinity Biotech PLC

Trinity Exploration & Production PLC

Trinity Industries Inc

TRINITY PETE TRUST CBI by Trinity Petroleum Trust

Trinity Petroleum Trust

TRINITY PLACE HLDGS INC by Trinity Place Holdings Inc.

Trinity Place Holdings Inc

Trinseo PLC

A stablecoin bill sprinting toward the legislative goal line could unleash trillions in global demand for U.S. Treasuries and cement the dollar's dominance in digital finance—at least if White House crypto adviser David Sacks gets his wish. But with President Donald Trump's family-linked crypto ventures casting a long political shadow, critics warn the future of fintech might come with a <a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/45995223/genius-stablecoin-bill-clears-senate-but-trumps-crypto-profits-loom-over-momentum">built-in conflict of interest</a>.
What Happened: Speaking to Bloomberg on Thursday, Sacks <a href="https://www.youtube.com/watch?v=sTBmFD7ZxZ4">said </a>the legislation, if signed into law by the House of Representatives, would provide the regulatory clarity needed to expand stablecoin issuance and institutional adoption.
The bet is that it will ultimately boost global use of U.S. dollar-based digital assets.
"There's already something like $250 billion in float of stablecoins… without there being a true regulatory framework in the United States," Sacks said. "I think you could see other economies start to dollarize from the bottom up… and that would create potentially trillions of dollars of new demand for U.S. Treasuries."
Sacks added that the bill would not only standardize audits and reserves for issuers but could also accelerate private sector involvement. 
"I think you'd see traditional financial players getting involved in it," he noted. "This would increase confidence in the industry."
He emphasized that the bill would move major stablecoin activity onshore and into a regulated framework. 
Also Read: <a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/46016270/utila-integrates-chorus-one-for-institutional-staking-on-ethereum-solana">Utila Integrates Chorus One For Institutional Staking On Ethereum, Solana</a>
Why It Matters: The bill faces opposition from most Democrats due to Trump's lucrative cryptocurrency ventures. World Liberty Financial, a firm his family runs, earned the president over $57 million last year. The firm also plans to launch <a href="https://www.benzinga.com/25/04/44767925/trump-family-backed-stablecoin-usd1-nears-launch-as-world-liberty-financial-teases-airdrop">a stablecoin called USD1</a>.
Critics warn of a deepening conflict of interest as Trump's administration simultaneously rolls back crypto regulations while his financial ties to the sector grow. 
The GENIUS Act &#8220;contains no restrictions to bar elected officials and their families from owning, buying, selling, or otherwise participating in stablecoin business ventures or prevent foreign countries from currying favor with President Trump by using his stablecoin to funnel money to him,&#8221; according to a letter <a href="https://www.banking.senate.gov/newsroom/minority/forwarding-merkley-warren-trump-linked-crypto-deal-is-a-staggering-conflict-of-interest">published</a> in May from the Senate Committee on Banking, Housing, and Urban Affairs.
In contrast, the bill&#8217;s supporters stress that the legislation strengthens consumer protections. If it passes, stablecoin issuers must maintain one-to-one reserves in U.S. bank accounts and undergo quarterly audits.
When asked about speculation about pairing the bill with broader market structure legislation, Sacks warned that combining the two could delay progress.
"The stablecoin bill is on the 10-yard line… the market structure bill hasn't even been taken up by the Senate," he said.
Sacks also pointed to the evolution of blockchain-based payments as a pivotal development enabled by the legislation. 
"Stablecoins will be used as payments… it's a payment system of the future," he said, calling it a faster and more efficient alternative to legacy systems.
He linked the legislative push to broader U.S. goals of maintaining competitiveness in financial innovation. "We don't want this innovation being driven offshore," he said. "The leading stablecoin issuer is offshore right now."
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/etfs/new-etfs/25/06/46015858/lion-group-shares-surge-20-after-600m-deal-for-hyperliquid-treasury-launch">Lion Group Shares Surge 20% After $600M Deal For Hyperliquid Treasury Launch</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

News

Politics

Sacks Says New Bill Allows Stablecoins To Soak Up Trillions—But Trump Ties Cloud The Push

Offerings

RBNE

Robin Energy Ltd.Announces Pricing Of 763,000 Share Registered Direct Offering At $5.25 Per Share

MBRX

Moleculin Biotech Prices Offering Of 16,080,000 Shares And Series E Warrants At $0.37/Share And Accompanying Warrant

Although the electoral victory of now-President Donald Trump during the 2024 political campaign helped briefly invigorate the hydrocarbon sector, oil stocks eventually succumbed to downward pressure. With the Trump administration implementing sweeping tariffs on key economic partners, the paradigm shift in the geopolitical framework created a cloud of uncertainty. Cynically, though, escalating tensions in the Middle East have renewed interest in fossil fuels.
Last week, Israel<a href="https://www.benzinga.com/news/events/25/06/45964856/trump-asks-everyone-to-immediately-evacuate-tehran-odds-of-us-striking-iran-spike-on-crypto-betting-platform"> launched an attack on Iran</a>, targeting nuclear energy and military sites. Fundamentally, the Israeli government views Iran as an existential threat. For many Americans, though, the main concern is whether or not the U.S. will get dragged into the conflict. Recently, lawmakers — including Sen. Bernie Sanders (I-VT) —<a href="https://www.benzinga.com/news/politics/25/06/45988135/bernie-sanders-slams-israels-illegal-attack-on-iran-says-absolutely-imperative-that-the-united-states-not-be-dragged-into-this-war"> expressed deep reservations</a> about the attack and the possibility of U.S. involvement.
A major concern that could cynically bolster the price of oil is the<a href="https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/06/45940903/a-thin-strip-of-water-keeps-the-world-economy-on-edge-will-it-trigger-a-100-oil-shock"> strategic chokepoint</a> of the Strait of Hormuz. Located between Iran and Oman, this waterway narrows to just two shipping lanes of only 2 nautical miles each, which greatly endangers global oil flows. Commodity analyst Daan Struyven warned that if Iranian oil infrastructure is damaged, it's possible that Brent crude could briefly spike above $90 per barrel.
Even more worrying, a wider escalation of the conflict may impact the strait, which could then push the price into triple-digit territory. Notably, almost a third of the world's seaborne oil moves across the passageway, setting the stage for potential mass disruption.
Outside factors can also contribute to a bullish backdrop for the oil market. While the Federal Reserve has<a href="https://www.benzinga.com/markets/macro-economic-events/25/06/46006680/powell-holds-line-on-interest-rates-blames-tariff-uncertainty-for-delay-in-cuts"> kept interest rates steady</a> due to inflation data not supporting rate cuts, shifts in economic viability may force the central bank into a more accommodative stance. If so, a dovish monetary backdrop could lift oil prices.
Still, not every data point supports hydrocarbons. A key factor to consider is supply. In recent years, U.S. oil production has<a href="https://www.benzinga.com/markets/esg/23/12/36185311/crude-conundrum-us-oil-production-hits-record-levels-but-energy-stocks-arent-pumping"> hit record levels</a>, applying downward pressure on prices. As such, investors may have both fundamental and technical headwinds to consider. With the Trump administration's big push toward<a href="https://www.benzinga.com/markets/commodities/25/04/44903411/trumps-2025-energy-policy-a-resurgence-of-fossil-fuel"> energy independence</a>, a risk exists that oil stocks could hit a technical plateau.
Moreover, it's worth pointing out the demand-side pressure. Thanks in part to the aforementioned tariffs, economic activity has slowed, leading to less consumption of oil. In addition,<a href="https://www.benzinga.com/25/04/44755934/us-q1-ev-sales-data-shows-106-yoy-growth-tesla-experiences-decline-but-still-dominates-domestic-ev-sales"> electric vehicle sales are booming</a>, and there's little evidence that the trend is declining. More legacy automakers are entering the electric fray, which may eventually drag down oil prices.
The Direxion ETFs: With compelling narratives on both sides of the aisle, traders have ample opportunity to attempt to extract short-term profits. For those seeking a straightforward way to speculate on oil, financial services provider Direxion offers two relevant products.
First, for optimistic traders, the <a href="https://www.direxion.com/product/daily-sp-oil-gas-exp-prod-bull-bear-2x-etfs?utm_source=Referral&amp;utm_medium=Native&amp;utm_source_platform=Benzinga&amp;utm_campaign=">Direxion Daily S&amp;P Oil &amp; Gas Exp. &amp; Prod. Bull</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GUSH#NYSE">GUSH</a>) seeks the daily investment results of 200% of the performance of the S&amp;P Oil &amp; Gas Exploration &amp; Production Select Industry Index. Second, for pessimistic market participants, the <a href="https://www.direxion.com/product/daily-sp-oil-gas-exp-prod-bull-bear-2x-etfs?utm_source=Referral&amp;utm_medium=Native&amp;utm_source_platform=Benzinga&amp;utm_campaign=">Direxion Daily S&amp;P Oil &amp; Gas Exp. &amp; Prod. Bear 2X Shares</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DRIP#NYSE">DRIP</a>) seeks 200% of the inverse performance of the aforementioned index.
In both cases, the main point of intrigue is the offering of a convenient mechanism for speculation. Typically, those interested in leveraged or short trades must engage the options market. However, the underlying derivative instruments feature unique complexities that may not align with every investor's needs. With Direxion ETFs, the units can be bought and sold much like any other public security, thus mitigating the learning curve.
Nevertheless, prospective buyers should be aware that leveraged and inverse ETFs carry significant risks. Primarily, traders must be cognizant of the often-extreme volatility that can erupt with these funds. Further, these Direxion ETFs are designed for exposure lasting no longer than one day. Holding beyond the recommended period may lead to positional decay due to the daily compounding effect.
The GUSH ETF: Since the start of the year, the GUSH ETF has lost roughly 8% of value. However, momentum from the geopolitical crisis has boosted GUSH by over 15% in the past month.
<ul class="wp-block-list">
<li>Previously, in late May to early June, GUSH's 50-day moving average acted as a support line. Since Israel's attack, the bull fund has been rocketing higher on strong volume.</li>
<li>The next several sessions will represent a major test for GUSH, particularly as it seems to have encountered resistance at the 200 DMA.</li>
</ul>
<figure class="wp-block-image"><img loading="lazy" decoding="async" width="1002" height="628" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/20091749/image-311.png" alt="" class="wp-image-956085" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/20091749/image-311.png 1002w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/20091749/image-311-300x188.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/20091749/image-311-768x481.png 768w" sizes="(max-width: 1002px) 100vw, 1002px" /></figure>
The DRIP ETF: While circumstances appeared positive for the bear fund, the DRIP ETF has now fallen more than 19% on a year-to-date basis.
<ul class="wp-block-list">
<li>In an almost inverse scenario to GUSH, the DRIP ETF encountered resistance imposed by the 20-day exponential moving average between late May to early June.</li>
<li>With the geopolitical crisis, DRIP has fallen on strong distributive volume. However, the bears may be attempting to build a baseline of support at the $9 level.</li>
</ul>
<figure class="wp-block-image"><img loading="lazy" decoding="async" width="1001" height="627" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/20091749/image-311.png" alt="" class="wp-image-956084" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/20091749/image-311.png 1001w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/20091749/image-311-300x188.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/20091749/image-311-768x481.png 768w" sizes="(max-width: 1001px) 100vw, 1001px" /></figure>
Featured image by <a href="https://pixabay.com/users/az1975-18732333/?utm_source=link-attribution&amp;utm_medium=referral&amp;utm_campaign=image&amp;utm_content=7166594">Az1975</a> from <a href="https://pixabay.com/photos/oil-gasoline-fuel-energy-crude-oil-7166594/">Pixabay</a>.

Long Ideas

Short Ideas

Technicals

Trading Ideas

ETFs

DRIP

GUSH

Escalating Middle East Tensions Shine Massive Spotlight On Direxion's Oil-Focused GUSH, DRIP ETFs

<ul>
<li>CRCL</li>
<li>TSLA</li>
<li>ASTS</li>
<li>GLD</li>
<li>AVIV</li>
<li>GOOGL</li>
<li>BULL</li>
<li>TEL</li>
<li>OSCR</li>
<li>RDDT</li>
</ul>
Data from <a href="https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment">https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment</a>
&nbsp;

ASTS

AVIV

BULL

CRCL

GOOGL

OSCR

RDDT

TSLA

Top 10 Trending Stocks On WallStreetBets As Of June 20, 2025 (Via Swaggy Stocks)

Cantor Fitzgerald analyst Matthew Vanvliet reiterates Salesforce (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRM#NYSE">CRM</a>) with a Overweight and maintains $325 price target.

Price Target

Reiteration

Analyst Ratings

Cantor Fitzgerald Reiterates Overweight on Salesforce, Maintains $325 Price Target

&#8220;It&#8217;s not that I&#8217;m lazy, it&#8217;s that I just don&#8217;t care.&#8221; That line from the 1999 cult classic &#8220;Office Space&#8221; movie might&#8217;ve gotten a laugh 26 years ago, but for a lot of working millennials today, it&#8217;s hitting uncomfortably close to home.
As one millennial recently put it in the r/Millennials <a href="https://www.reddit.com/r/Millennials/comments/1lahcem/the_older_i_get_and_the_farther_in_my_career_i_go/">subreddit</a>: &#8220;The older I get and the farther in my career I go, the more I realize how deadly accurate &#8216;Office Space&#8217; was.&#8221; That simple statement launched a tidal wave of agreement from thousands of people, most of them somewhere between their 30s and 40s, grinding through careers that feel increasingly pointless.
Don't Miss:
<ul class="wp-block-list">
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — <a href="https://www.benzinga.com/money/boxabl-scaling-fast-from-spacex-orders-to-600-homes-built-this-60k-foldable-home-may-be-the-future-of-housing">this is your last chance to become an investor for $0.80 per share.</a></li>
<li>Peter Thiel turned $1,700 into $5 billion—now accredited investors are eyeing this software company with similar breakout potential. Learn how you can <a href="https://www.benzinga.com/money/how-peter-thiel-turned-his-roth-ira-into-5-billion-and-why-accredited-investors-are-now-eyeing-this-smartphone-disruptor">invest with $1,000 at just $0.30/share.</a></li>
</ul>
<h2 class="wp-block-heading">From Satire To Reality</h2>
When the movie first came out, many viewers saw it as an absurdist comedy. Now, it feels like a documentary. &#8220;It came out when I was in high school and I thought the exact same,&#8221; one person wrote. &#8220;I remember a couple years later in my first office job, like a week in I realized &#8216;it wasn&#8217;t satire, it was a f&#x2A;&#x2A;&#x2A;ing documentary.'&#8221;
Another echoed the sentiment: &#8220;Watched it again recently and was like &#8216;oh sh&#x2A;t.'&#8221;
A number of commenters shared that their daily work lives are basically spreadsheets, emails and meetings with no clear purpose. &#8220;People ask me what I do at my job, and I can't even explain it. I send emails and make spreadsheets, homie,&#8221; one person said. &#8220;My decks are basically full reports with a lot of data and they get referred to for years afterwards. I don&#8217;t even get to present them.&#8221;
Trending: Maximize saving for your retirement and cut down on taxes: <a href="https://www.benzinga.com/money/wideradvisor-retirement-planning">Schedule your free call with a financial advisor to start your financial journey – no cost, no obligation</a>.
<h2 class="wp-block-heading">Promotions And Raises? Don&#8217;t Count On It</h2>
Many talked about doing great work, only to <a href="https://www.benzinga.com/personal-finance/management/25/06/45726529/four-and-a-half-years-in-a-worker-sees-a-new-hire-earn-20-more-now-theyre-asking-if-loyalty-is-the-most-expensive-career-mistake">get tiny raises</a> or none at all. &#8220;I crunched for three months at the beginning of 2025, usually 10-hour days with a couple of 12-hour days&#8230; Hit the target on both [projects], got a 0.5% raise shortly after. Lowest I&#8217;ve ever gotten, in a year where I easily did my best work,&#8221; someone wrote.&nbsp;
Another added, &#8220;Got a huge promotion/raise I&#8217;d been trying and failing to get for 5 years&#8221;—but only after they stopped putting in effort entirely after their dad passed away.
Several said it outright: if you care too much, you&#8217;re either ignored or punished. &#8220;The squeaky wheel gets more work assigned to them for no additional pay or prospects for promotion.&#8221;
<h2 class="wp-block-heading">Office Culture Is Dead</h2>
The idea of the workplace as a &#8220;family&#8221; was torn apart by users. One wrote, &#8220;I naively approached this job with &#8216;we&#8217;re a family&#8217; energy.&#8221; A year later? They keep to themselves now. &#8220;People are petty, insecure, control-hungry, arrogant, defensive. Humorless.&#8221;
Others pointed to open office layouts and <a href="https://www.benzinga.com/25/05/45556921/mark-zuckerberg-slams-endless-one-on-one-meetings-says-i-just-like-explode-without-open-blocks-of-time-in-the-calendar">endless meetings as morale-killers</a>. &#8220;I'm still wrapping my head around 30-minute daily standup meetings and then filling out a &#8216;What I Did Today&#8217; in Slack.&#8221;
See Also: Can you guess how many retire with a $5,000,000 nest egg? <a href="https://www.benzinga.com/money/5mil-nest-egg-adv">The percentage may shock you</a>.
<h2 class="wp-block-heading">Realizations Stack Up With Age</h2>
Many millennials admitted that the further they move up the corporate ladder, the more hollow it feels. One said their goal is now simply to &#8220;do half the work for twice the pay&#8221; as a program manager.
Others are focused on survival, not ambition. &#8220;You only have to work hard enough to be cheaper to keep than replace,&#8221; one comment read. And if there&#8217;s one consistent theme, it&#8217;s this: working hard doesn't guarantee anything.
One person summed up the entire vibe: &#8220;Watching that movie growing up it's like okay, that's kinda funny but he's not being serious. Now&#8230; now it's gospel.&#8221;
After thousands of comments, one thing is obvious: &#8220;Office Space&#8221; isn&#8217;t funny because it&#8217;s exaggerated—it's funny because it's true. And for a generation that grew up being told to find purpose in their work, discovering that the working world often rewards apathy instead of passion feels like a bait-and-switch.
Read Next: <a href="https://www.benzinga.com/money/gbr-savings-by-age">If You're Age 35, 50, or 60: Here&#8217;s How Much You Should Have Saved Vs. Invested By Now</a>
Image: Shutterstock

A Millennial Says, The Older I Get And The Further In My Career I Go, The More I Realize How Deadly Accurate 'Office Space' Was

<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="900" height="600" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/06/19081600/Taobao-0618-1.png" alt="" class="wp-image-14612" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2025/06/19081600/Taobao-0618-1.png 900w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/06/19081600/Taobao-0618-1-300x200.png 300w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/06/19081600/Taobao-0618-1-768x512.png 768w" sizes="(max-width: 900px) 100vw, 900px" /></figure>
Embedded links in recommendation notes on the popular lifestyle platform will take buyers directly to items for sale in Alibaba's Tmall and Taobao marketplaces
Taobao and Tmall, two core marketplaces operated by&nbsp;Alibaba Group Holding Ltd.&nbsp;(BABA.US; 9988.HK), recently entered a landmark partnership with lifestyle social media sensation&nbsp;RedNote, in the former's latest step to bring its core e-commerce services closer to consumers in their everyday lives. The tie-up is just the latest by two of China's largest e-commerce marketplaces, as they look for new and innovative ways to engage consumers through steps like integrating links to products in online conversations and videos.
At the same time, Taobao and Tmall are giving their thousands of online merchants better tools to make their marketing and back-office functions more efficient, often using the power of AI. A company spokesperson discussed those developments and more in a recent interview with Bamboo Works.
Q:&nbsp;Taobao and Tmall have recently announced a partnership with RedNote. Could you tell us more about the collaboration?
A: Taobao and Tmall's strategic partnership with RedNote represents a significant step in bridging content and commerce, offering consumers a seamless path from product discovery to purchase. The partnership enables merchants to embed product links from their Taobao and Tmall stores directly into recommendation posts on RedNote. Users can tap on these links and be redirected to the Taobao app to complete their purchases.
The partnership also includes the launch of joint merchant accounts and performance dashboards, allowing merchants to track the full journey from content exposure on RedNote to completed orders on the Taobao app in real-time. To further support merchant success, Taobao and Tmall will invest in amplifying hero products featured in RedNote posts, providing marketing resources and performance advertising tools to boost product visibility and engagement.
Q: Is this the first time Taobao and Tmall have struck such a major partnership with an outside company and what's the strategic importance?
A: We have a strong track record of successful partnerships with other platforms as part of our "user-first" strategy and merchant-friendly initiatives. Currently, Taobao and Tmall work with over 200 internet platforms, ranging from social media to mobile payments, supporting brand growth through expanded traffic channels, diversified content formats, and omni-channel operations.
Last September, Taobao and Tmall partnered with WeChat Pay, which expanded payment options for consumers. Additionally, last October, JD Logistics fully integrated with Taobao and Tmall, providing comprehensive services to Taobao and Tmall merchants that encompass the entire supply chain process, including warehousing, express delivery, and freight.
These developments represent significant milestones for China's cross-platform interconnectivity and enhancing Taobao and Tmall's competitiveness. All these partnerships create a more seamless and convenient experience for consumers while opening up new business opportunities for merchants, benefitting both.
Q: Do you see content-driven e-commerce as key to driving further user and business growth, and can you elaborate on how?
A: The partnership between Taobao and Tmall and RedNote bridges content with commerce, reflecting our commitment to supporting brands. At its TopTalk annual merchant conference in March, Tmall announced a series of new initiatives to support brands in 2025, including measures to attract users across channels and the extension of its commission rebate scheme to cover all categories.
Tmall President Liu Bo said the RedNote collaboration marks a new chapter in the marketplace's support for brand growth in 2025. He added that combining Taobao and Tmall's commerce expertise with RedNote's strength in lifestyle content, will help brands reach consumers more effectively and drive incremental growth.
Q: What other initiatives are Taobao and Tmall taking to enhance overall user experience and overall stickiness?
A: With 1 billion annual active consumers, Taobao and Tmall are continuously introducing new initiatives to enhance user experience. To convert more new users into loyal consumers and ultimately VIP members, Taobao and Tmall will increase investment in initiatives such as exclusive 88VIP benefits this year, aiming to cultivate repurchasing habits and deepen long-term engagement.
To boost repeat purchases, Tmall is increasing investment in not only platform-wide loyalty programs like 88VIP but also in brand-specific ones. Brands will be able to increase member engagement through more membership access points across Taobao search results, personalized recommendations, and shopping carts.
Q: I understand Alibaba has leveraged AI-powered technology to support merchants on your e-commerce platforms. Can you tell us more about these tools?
A: Taobao and Tmall have been integrating advanced AI technologies into every stage of the e-commerce process, from product recommendations and bidding optimization to content creation and performance analytics. These AI tools are designed to transform the digital shopping experience while boosting operating efficiency for merchants.
At the 2025 TopTalk conference, we introduced major upgrades to the merchant AI toolkit, including new image-to-video generation capabilities within the AI-generated Content (AIGC) tool and an advanced marketing bidding model that has demonstrated an average 12% boost in campaign ROI through automated bidding strategies. Additionally, our AI customer service chatbots have continued to evolve, offering increasingly sophisticated support.
To date, Taobao and Tmall's AI-powered e-commerce toolkit, launched last year, has served 7 million merchants. This May alone, merchants reduced their marketing expenses by generating over 100 million marketing images, videos, and text and conducted over 1.8 million AI agent services for traffic analysis and more.
Our new "Image-to-Video" AIGC product has generated over 1.5 million videos since its beta launch in April. It enables merchants to generate up to 20-second videos from one or more product images, and provides additional features such as one-click editing, smart refinement, and script-based production
Q: Can you tell us about your Quanzhantui marketing solution?
A: Quanzhantui launched in April 2024 and is an important AI-powered marketing tool to help merchants market effectively and drive business growth. Over 1.4 million merchants have enhanced their marketing efficiency with the aid of Quanzhantui. As our CEO Eddie Wu explained in our earnings call last August, achieving strong sales performance requires more than just having a product in place, and Quanzhantui can help merchants to streamline operations and optimize marketing efficiency.
For the quarter through March this year, our customer management revenue grew 12% year-over-year to 71.1 billion yuan ($9.8 billion), primarily driven by the improvement of take rate, which benefited from the impact of software service fees and the increasing penetration of Quanzhantui.
Q: How are these new products and offerings driving user growth?
A: Taobao and Tmall are committed to enhancing support for product launches, providing brands with powerful tools and resources to capture market share and attract new consumers. Specifically, Taobao and Tmall have introduced new marketing tools that leverage AI and data analytics, along with more prominent ad placements and an extended new product incubation cycle from 30 days to 90 days, giving brands more time to build awareness and gain traction.
The "Tmall Super Launch" campaign has been particularly successful, enabling 34,000 new products to achieve sales exceeding 10 million yuan each. This feature alone generated a total of 100 billion yuan in sales in 2024.

Equities

Opinion

Interview

BABA

Alibaba Talks To Bamboo Works On RedNote Partnership

Cantor Fitzgerald analyst Eric Schmidt reiterates Prothena Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRTA#NASDAQ">PRTA</a>) from Neutral to Neutral.

PRTA

Cantor Fitzgerald Reiterates Neutral on Prothena Corpto Neutral

Accenture Plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACN#NYSE">ACN</a>) stock declined on Friday following the release of its <a href="https://www.benzinga.com/pressreleases/25/06/b46022011/accenture-reports-third-quarter-fiscal-2025-results">third-quarter 2025 results</a>.
The company reported quarterly earnings of $3.49 per share, topping the <a href="https://www.benzinga.com/earnings">analyst consensus estimate of $3.31</a>.
The company reported sales of $17.7 billion, slightly exceeding the analyst consensus estimate of $17.30 billion. Sales increased 8% in U.S. dollars and 7% in local currency.
Also Read: <a href="https://www.benzinga.com/news/large-cap/25/05/45538647/accenture-dell-nvidia-deliver-on-premise-ai-solution-for-regulated-industries" target="_blank" rel="noreferrer noopener">Accenture, Dell, NVIDIA Deliver On-Premise AI Solution For Regulated Industries</a>
Consulting revenues were $9.01 billion, an increase of 7% in U.S. dollars and 6% in local currency. Managed Services revenues reached $8.72 billion, an increase of 9% in U.S. dollars and local currency.
Products revenues reached $5.34 billion, up 7% both in U.S. dollars and local currency. Health &amp; Public Service revenues increased by 7% in U.S. dollars and local currency to $3.78 billion.
Financial Services revenue reached $3.28 billion, up 13% in U.S. dollars and local currency. Resources revenue was $2.41 billion, up 5% in U.S. dollars and 4% in local currency.
Communications, Media &amp; Technology revenue was $2.91 billion, up 5% both in U.S. dollars and in local currency.
New bookings for the quarter were $19.7 billion, a decrease of 6% in U.S. dollars and 7% in local currency. This total comprised $9.08 billion in Consulting new bookings and $10.62 billion in Managed Services new bookings.
Generative AI new bookings reached $1.5 billion in the quarter <a href="https://www.benzinga.com/25/03/44415440/accenture-q2-fy2025-earnings-almost-inline-with-expectations-new-bookings-fall-to-209-billion-tightens-annual-sal">versus $1.4 billion</a> in the second quarter.
Operating margin of 16.8%, an increase of 80 basis points, and a rise of 40 basis points compared to adjusted&nbsp;operating margin.
Accenture held $9.64 billion in cash and equivalents as of May 31. It generated $3.52 in free cash flow during the quarter.
Accenture has declared $1.48 per share dividend, payable on August 15, 2025. During the third quarter of fiscal 2025, Accenture repurchased or redeemed 6 million shares for a total of $1.8 billion, including 5.7 million shares acquired through open market transactions. As of May 31, 2025, Accenture had approximately $3.3 billion remaining in its share repurchase authority and about 623 million total shares outstanding.
Accenture announced a <a href="https://www.benzinga.com/pressreleases/25/06/b46022235/accenture-changes-growth-model-to-reinvent-itself-for-the-age-of-ai">strategic overhaul of its growth model</a>, effective September 1, 2025, with a sharpened focus on AI. As part of this change, the company will launch a new Reinvention Services unit.
Leadership changes associated with this new structure include Manish Sharma, Accenture&#8217;s current CEO of the Americas, transitioning to Chief Services Officer. John Walsh, Accenture&#8217;s current global COO, will succeed Sharma as CEO of the Americas. Kate Hogan, currently COO of the Americas, will become the global COO, succeeding Walsh.
Guidance: Accenture narrowed its fiscal year 2025 revenue growth outlook to 6%-7% (prior 5%-7%) in local currency. The company forecasts 2025 diluted earnings of $12.77-$12.89 (prior $12.55-$12.79) per share compared <a href="https://www.benzinga.com/calendars/guidance">to the consensus of $12.75</a>.
Price Action: ACN stock was trading lower by 5.19% to $290.47 premarket at last check Friday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/06/46005368/meta-amazon-booking-best-positioned-for-agentic-ai-opportunity-says-analyst" target="_blank" rel="noreferrer noopener">Meta, Amazon, Booking Best Positioned For Agentic AI Opportunity, Says Analyst</a></li>
</ul>
Photo via Shutterstock

Earnings

Guidance

Movers

Tech

Accenture New Bookings Fall In Q3, But It Raises Profit Outlook

WIIM

Kroger shares are trading higher after the company reported better-than-expected Q1 adjusted EPS results.

<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="900" height="600" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/06/19081847/Alphamab.png" alt="" class="wp-image-14615" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2025/06/19081847/Alphamab.png 900w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/06/19081847/Alphamab-300x200.png 300w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/06/19081847/Alphamab-768x512.png 768w" sizes="(max-width: 900px) 100vw, 900px" /></figure>
The founder of the cancer drug developer has cashed out part of his holdings after the stock hit a price peak, raising questions about the firm's earnings outlook
Key Takeaways:
<ul class="wp-block-list">
<li>The company finally posted an annual profit last year, but the achievement came on the back of upfront licensing payments for its experimental drugs</li>
<li>Rights to Alphamab's advanced drug candidates in mainland China have now been licensed out, capping the firm's growth potential from here</li>
</ul>
China's drug discovery sector has roared back to life this year after a three-year slump, leading a rally in the overall Hong Kong stock market.
One of the standout performers has been cancer therapy specialist&nbsp;Alphamab Oncology&nbsp;(9966.HK), which more than doubled in market value, outstripping a 65% overall jump in the Hang Seng Innovative Drug Index.
But the rebound has also tempted shareholders to cash out their winnings.
Last Friday, Alphamab&nbsp;<a href="https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0606/2025060601575.pdf">announced</a>&nbsp;that a family trust controlled by a key shareholder had sold a block of 14.6 million shares on June 5 for approximately HK$117 million. The divestment at HK$8.05 ($1.03) per share reduced the stake controlled by founder and chairman Xu Ting to 31% from 32.5%, although he retains a majority interest.
The sale took advantage of an elevated price after Alphamab stock hit its highest level since November 2023, riding on a wave of positive news for the industry.
The rally was fueled by a $6 billion landmark licensing deal between&nbsp;3SBio&nbsp;(1530.HK) and&nbsp;Pfizer&nbsp;(PFE.US), as well as a 25% surge by industry leader&nbsp;Hengrui Pharmaceuticals&nbsp;(600276.SH; 1276.HK) after its Hong Kong stock market debut. Alphamab's share price duly rose nearly 33% between May 19 and May 23. Just over a week later on June 2 the company began the share sale process, which was completed a few days afterwards.
Alphamab specializes in developing biopharmaceuticals for the targeted treatment of tumors. One of its key products is the immune checkpoint drug envafolimab, a PD-L1 oncology product approved in 2021. After being in business for nine years, the company finally achieved its first full-year profit in 2024. While on paper the company looks to be reaping the rewards of its research efforts, the quick cash-out rings an alarm bell for investors.
A closer look at Alphamab's earnings record sheds some light on the motivation behind the move.
The company's annual revenues leapt 192% to 640 million yuan ($8.9 million) last year, pushing its bottom line from a net loss of 211 million yuan in 2023 to a profit of 166 million yuan. But core revenue from the only Alphamab drug launched so far on the market, envafolimab, actually fell 18.46% to 159 million yuan from the prior year. The decisive factor for profits was actually proceeds from three licensing agreements, amounting to around 464 million yuan in one-off fees and 1.88 million yuan in staggered payments.
<h4 class="wp-block-heading">Deals momentum flagging</h4>
It was a big year for drug development deals. In January, Alphamab inked a $700 million agreement with Glenmark for envafolimab, a $616 million deal with ArriVent for joint work on antibody-drug conjugates, and a 3.08 billion yuan deal with&nbsp;CSPC Pharmaceutical Group&nbsp;(1093.HK) for the dual-target HER2 antibody-drug conjugate JSKN003.
Those headline amounts include upfront fees and milestone payments, but the deferred sums depend on hitting defined R&amp;D targets and may not ultimately materialize. The parties did not disclose specific figures for upfront payments in the first two collaborations, while the upfront payout for the deal with CSPC Pharmaceutical Group was a mere 400 million yuan.
The track record for previous Alphamab deals highlights the risks. Its U.S. partner&nbsp;Tracon Pharmaceuticals&nbsp;(TCON.US) pulled the plug on joint development of envafolimab after the drug delivered disappointing trial results when used in a combined therapy to treat sarcoma patients. A Phase Three trial for Alphamab's other core product, KN046 for pancreatic cancer, also failed to achieve the targeted survival endpoint. Previous trials of KN046 to treat a type of lung cancer also yielded unsatisfactory results.
Otherwise, rights within mainland China to Alphamab's two other advanced pipelines, KN026 and JSKN003, have also been licensed out to CSPC Pharmaceutical Group. Even if those drugs are successfully launched in China, Alphamab will only receive a portion of the proceeds, limiting its earnings growth potential. Moreover, the firm's HER2 antibody-drug conjugate, JSKN003, faces fierce competition from Zymeworks, Chia Tai Tianqing, and XuanZhu Biopharm, which are working on similar products.
Licensing deals may bump up the bottom line in the short term but only sustained returns from commercially viable drugs can offer a stable income.
Currently, Alphamab trades at a price-to-earnings (P/E) ratio of 44 times, even higher than the 30 times for&nbsp;Henlius Biotech&nbsp;(2696.HK), which has achieved profitability through product sales. Alphamab's numerous collaborations demonstrate its R&amp;D expertise but leave investors at risk of a setback if profits prove to be fleeting.

Asia

Asset Sales

Alphamab Stake Sale Could Signal Harder Times Ahead

<h3>Gainers</h3>
<table>
<thead>
<tr>
<th>Symbol</th>
<th>Name</th>
<th align="right">Price</th>
<th align="right">Change ($)</th>
<th align="right">Change (%)</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLY#NYSE">XLY</a>)</td>
<td>SPDR Select Sector Fund - Consumer Discretionary</td>
<td align="right">211.66</td>
<td align="right">1.23</td>
<td align="right">0.58</td>
<td>7.1K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLF#NYSE">XLF</a>)</td>
<td>SPDR Select Sector Fund - Financial</td>
<td align="right">50.43</td>
<td align="right">0.21</td>
<td align="right">0.41</td>
<td>285.8K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>)</td>
<td>SPDR Select Sector Fund - Energy Select Sector</td>
<td align="right">88.40</td>
<td align="right">0.32</td>
<td align="right">0.36</td>
<td>366.6K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLV#NYSE">XLV</a>)</td>
<td>SPDR Select Sector Fund - Health Care</td>
<td align="right">133.59</td>
<td align="right">0.35</td>
<td align="right">0.26</td>
<td>2.3K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLK#NYSE">XLK</a>)</td>
<td>SPDR Select Sector Fund - Technology</td>
<td align="right">242.16</td>
<td align="right">0.55</td>
<td align="right">0.22</td>
<td>11.8K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLB#NYSE">XLB</a>)</td>
<td>Materials Select Sector SPDR</td>
<td align="right">87.11</td>
<td align="right">0.10</td>
<td align="right">0.11</td>
<td>932</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLC#NYSE">XLC</a>)</td>
<td>The Communication Services Select Sector SPDR Fund</td>
<td align="right">103.55</td>
<td align="right">0.08</td>
<td align="right">0.07</td>
<td>1.2K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLI#NYSE">XLI</a>)</td>
<td>SPDR Select Sector Fund - Industrial</td>
<td align="right">142.31</td>
<td align="right">0.10</td>
<td align="right">0.07</td>
<td>1.4K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLU#NYSE">XLU</a>)</td>
<td>SPDR Select Sector Fund - Utilities</td>
<td align="right">80.59</td>
<td align="right">0.03</td>
<td align="right">0.03</td>
<td>1.2K</td>
</tr>
</tbody>
</table>
No loser in today's Pre-market session. 
<a href="https://pro.benzinga.com/?utm_source=insights">Pulled from Benzinga Pro data</a> the above sector movers alert assists traders in understanding macro-level trends and market variations. Traders will look for sector movers providing information on sectors that are over- or under-performing, deriving these results into investing decisions on exchange-traded funds (ETFs) or individual tickers in those sectors. 
To read more about sector movers, <a href="https://www.benzinga.com/movers">click here</a>.

Sector ETFs

Pre-Market Outlook

Select Sector SPDR-Consumer Discretionary

Leading And Lagging Sectors For June 20, 2025

UBS maintains Lundin Mining (TSX:<a class="ticker" href="https://www.benzinga.com/stock/LUN#TSX">LUN</a>) with a Neutral and raises the price target from C$13 to C$14.

TSX:LUN

UBS Maintains Neutral on Lundin Mining, Raises Price Target to C$14

Cantor Fitzgerald analyst Li Watsek initiates coverage on Replimune Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REPL#NASDAQ">REPL</a>) with a Overweight rating.

Initiation

REPL

Cantor Fitzgerald Initiates Coverage On Replimune Group with Overweight Rating

<a href="https://about.fb.com/news/2025/06/introducing-oakley-meta-glasses-a-new-category-of-performance-ai-glasses/" title="https://about.fb.com/news/2025/06/introducing-oakley-meta-glasses-a-new-category-of-performance-ai-glasses/">https://about.fb.com/news/2025/06/introducing-oakley-meta-glasses-a-new-category-of-performance-ai-glasses/</a>

Meta Announces Oakley Meta Glasses, Releasing July 11 For $499; Rest Of Collection At $399 Later This Summer

BASE

Couchbase To Be Acquired By Haveli Investments For $24.50 Per Share In Cash

LGCL

Lucas GC Limited Announces Pricing Of 32,150,000 Share Follow-On Offering At Public Offering Price Of $0.20/Share

CDZI

Cadiz Signs Signs MOU With MOU To Develop A Clean Energy Campus At Cadiz Ranch In The Mojave Desert

10 analysts have expressed a variety of opinions on Helmerich &amp; Payne (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HP#NYSE">HP</a>) over the past quarter, offering a diverse set of opinions from bullish to bearish.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">4</td>
<td align="right">2</td>
<td align="right">1</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $23.0, a high estimate of $32.00, and a low estimate of $17.00. A 20.69% drop is evident in the current average compared to the previous average price target of $29.00. 
<img src="https://www.benzinga.com/files/images/story/2025/1750424465_0.png" alt="price target chart" />
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
A clear picture of Helmerich &amp; Payne's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>David Anderson</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$17.00</td>
<td>$20.00</td>
</tr>
<tr>
<td>Sean Meakim</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$17.00</td>
<td>$25.00</td>
</tr>
<tr>
<td>Scott Gruber</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$19.00</td>
<td>$25.00</td>
</tr>
<tr>
<td>Daniel Kutz</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$20.00</td>
<td>$27.00</td>
</tr>
<tr>
<td>David Anderson</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$20.00</td>
<td>$24.00</td>
</tr>
<tr>
<td>Scott Gruber</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Buy</td>
<td>$25.00</td>
<td>$32.00</td>
</tr>
<tr>
<td>Charles Minervino</td>
<td>Susquehanna</td>
<td>Lowers</td>
<td>Positive</td>
<td>$28.00</td>
<td>$43.00</td>
</tr>
<tr>
<td>Neil Mehta</td>
<td>Goldman Sachs</td>
<td>Lowers</td>
<td>Sell</td>
<td>$25.00</td>
<td>$32.00</td>
</tr>
<tr>
<td>Scott Gruber</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Buy</td>
<td>$32.00</td>
<td>$33.00</td>
</tr>
<tr>
<td>Daniel Kutz</td>
<td>Morgan Stanley</td>
<td>Announces</td>
<td>Underweight</td>
<td>$27.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Helmerich &amp; Payne. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Helmerich &amp; Payne compared to the broader market.</li>
<li>Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Helmerich &amp; Payne's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Helmerich &amp; Payne's market standing. Stay informed and make data-driven decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/HP/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Helmerich &amp; Payne analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">you can start by tracking it here</a>.
<h2>Delving into Helmerich &amp; Payne's Background</h2>
Helmerich &amp; Payne Inc provides performance-driven drilling solutions and technologies that are intended to make hydrocarbon recovery safer and more economical for oil and gas exploration and production companies. The Company focus on the drilling segment of the oil and gas production value chain. Company operates in North America, Gulf of Mexico, and other international places such as Argentina, Australia, Bahrain, Colombia and the United Arab Emirates (UAE). Also own and operates a limited number of commercial real estate properties located in Tulsa, Oklahoma. It's real estate investments include a shopping center and of undeveloped real estate projects.
<h3>Unraveling the Financial Story of Helmerich &amp; Payne</h3>
Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
Revenue Growth: Helmerich &amp; Payne's remarkable performance in 3M is evident. As of 31 March, 2025, the company achieved an impressive revenue growth rate of 47.69%. This signifies a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Energy sector.
Net Margin: Helmerich &amp; Payne's net margin excels beyond industry benchmarks, reaching 0.12%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Helmerich &amp; Payne's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of 0.04%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): Helmerich &amp; Payne's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of 0.02%, the company may face hurdles in achieving optimal financial performance.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.76.
<h2>The Basics of Analyst Ratings</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Expectations For Helmerich & Payne's Future

Press Releases

Trinity Capital Inc. Provides $68.75 Million in Growth Capital to CMR Surgical

Trinity Capital Inc. Provides Details for First Quarter 2025 Financial Results and Earnings Call

Trinity Capital Inc. Funds $220 Million of Investments in the First Quarter of 2025

Trinity Capital Inc. Receives New Investment Grade Rating from Moody's

Trinity Capital Inc. Reports First Quarter 2025 Financial Results

Fintech

Trinity Capital Inc. Provides $15 Million in Growth Capital to Lendflow

Entertainment

General

Trinity Capital Inc. Provides $62.7 Million in Growth Capital to Atmosphere TV

Trinity Capital Inc. Provides $40 Million in Growth Capital to Paytient

Insurance

Paytient Secures $40 Million from Trinity Capital to Fuel Market Expansion

Dividends

Trinity Capital Inc. Declares Cash Dividend of $0.51 per Share for the Second Quarter of 2025

Comments

Trinity Cap

뉴스

파트너 / 기고자

벤징가 글로벌